Conference Material
|
Abstract
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis
Arana B,
Lopez L,
Velez ID,
Llanos-Cuentas A,
Boni MF,
Rode J
View HTML
View PDF
Share
Download
Download
View PDF
Share
Similar Content
Loading...
Loading...
Loading...
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis | Conference Material / Abstract | MSF Science Portal
Abstract
Countries
Colombia
Peru
Subject Area
neglected tropical diseases
cutaneous leishmaniasis
Languages
English
Published Date
13 May 2020
Conference
MSF Scientific Days International 2020